Skip to content

A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST)

A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST): A Randomized Pilot Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06404008
Acronym
REST
Enrollment
20
Registered
2024-05-08
Start date
2024-07-15
Completion date
2025-07-02
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Dyspnea, Stress

Brief summary

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with COPD.

Detailed description

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with chronic obstructive pulmonary disease (COPD). The intervention is based on the breathing techniques of Pranayama. It was developed with patient and stakeholder input and is targeted for individuals with COPD who have moderate levels of stress and symptom burden. The intervention is a 15-minute breathing protocol which will be taught to participants and subsequently evaluated in a clinic setting with surveys, lung function, and cardiac assessments. This intervention will be pre-tested in 6 individuals, revised, and piloted in 30 individuals (15 in intervention group, 15 in control group). This study will answer the question of 1) whether a controlled breath protocol is feasible, acceptable, and safe for patients with COPD and 2) whether any modifications to the intervention are needed for a future multicenter trial to be proposed and conducted after the completion of the pilot trial. We will also 3) obtain sufficient estimates of variability in stress measures to inform statistical planning of a future trial.

Interventions

BEHAVIORALREST

After randomization, individuals will attend an in-person training session in the REST protocol. This is a 15 minute controlled breath protocol that includes 3 yoga breathing techniques: 3-part dirgha breath, alternate nostril breathing, and 2:1 breathing. Each technique will be completed for 5 minutes, for a total of 15 minutes. After the training session, participants will practice the REST protocol for 15 minutes twice a day with guidance from research staff over zoom (Days 1-7) with daily COPD education including inhaler technique, nutrition, vaccinations, tobacco cessation counseling, and exacerbation education. On Day 8, participants will attend the Trial Session where they will complete the REST protocol (15 minutes) while vitals, lung function, and ECG measurements are taken. Surveys will be administered before and after the REST protocol to document patient reported stress and dyspnea.

OTHEREducation

After randomization, individuals will attend an in-person education session led by a research coordinator. For the following 7 days, the research staff will call patients daily and provide daily COPD education including inhaler technique, nutrition, vaccinations, tobacco cessation counseling, and COPD exacerbation education. On Day 8, participants will attend the Trial Session where they will do spontaneous breathing (15 minutes) while vitals, lung function, and EKG measurements are taken. Surveys will be administered before and after the spontaneous breathing period to document patient reported stress and dyspnea. After the study, participants will be asked to complete a close out survey and interview over zoom.

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Only the statistician will be blinded to study group

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of spirometry confirmed COPD (FEV1/FVC \<0.70 + FEV1\<80%) * Perceived Stress Scale \> 13 * Age \>40 years old * Able to read, write, and speak in English * Able to attend 1 in person training session and 1 in person trial sessions

Exclusion criteria

* Current regular practice of breathing exercises or pranayama * No access to internet or telephone * Recent hospitalization for COPD exacerbation or any reason in the past 30 days * Other primary lung disease (ILD, asthma, bronchiectasis) by self-report or chart review * Non-correctable hearing impairment (i.e. hearing impairment despite hearing aids) * Severe cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Acceptability (quantitative)6 monthsPost-intervention survey on intervention acceptability with Likert scale rated 1 to 10; 10 being most acceptable. Overall average score ≥8 of 10 defined as acceptable. Will assess patient reported enjoyment, difficulty, and adherence
Intervention Feasibility6 monthsIG: Completion of 2 in-person sessions (1 training, 1 trial) along with \>80% of daily individual practice of breathing protocol (15 minute twice daily)
Trial feasibility6 monthsRates of screening, enrollment, retention, reasons for exclusion and refusals, and attrition. Attrition goal \<10% throughout study period.
Acceptability (qualitative)6 monthsPost-intervention semi-structured, in-depth interviews by telephone conducted by study coordinator to explore acceptability, barriers, facilitators, and survey burden

Secondary

MeasureTime frameDescription
Mindful Attention Awareness ScaleDay 0, Day 8The MAAS is a 15-item scale designed to assess a core characteristic of dispositional mindfulness, namely, open or receptive awareness of and attention to what is taking place in the present
Perceived Stress ScaleDay 0, Day 810-item questionnaire with a score of 0-40, with higher scores indicating higher levels of stress.
Modified Medical Research Council dyspnea scaleDay 0, Day 8Self-rating tool to measure the degree of disability that breathlessness poses on day-to-day activities on a scale from 0 to 4

Other

MeasureTime frameDescription
Lung FunctionDay 0, Day 8Forced expiratory volume in 1 second (L), Forced vital capacity, Inspiratory capacity
Heart rate variabilityDay 0, Day 8Derived from 10-second ECG

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026